INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus • Minnesota
The Company’s 1999 Incentive Stock Option Plan (“Plan”), as amended through October 23, 2003, was created for the purpose of encouraging ownership of shares of the Common Stock of the Company (“Common Shares”) by key employees. The option is intended to qualify as an incentive stock option under Section 422A of the Internal Revenue Code of 1986, as amended.
LEASE AGREEMENTLease Agreement • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus
THIS LEASE AGREEMENT, made this 31st day of January, 2004 by and between JAMES JAGODZINSKI d/b/a JAGODZINSKI PROPERTIES (“Landlord”) and Enpath Medical, Inc.; a Minnesota corporation (“Tenant”);
ASSIGNMENT OF LEASEAssignment of Lease • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus • Minnesota
This Assignment relates to the tenant’s interest under that certain lease (the “Lease”) originally entered into June 15, 1998, between Principal Mutual Life Insurance Company (“Principal”), as landlord, and R.F. Machining, Inc., a Minnesota corporation (“R.F. Machining”), as tenant, by which the premises therein (commonly described as 13,548 square feet of net rentable area located at 7448 West 78th Street, Bloomington, Minnesota, and more particularly described in the Lease (the “Leased Premises”)) were demised for a term commencing on June 1, 1998, and ending on May 31, 2005. (The Lease was subsequently amended to increase the size of the Premises and to change the termination date of the Lease to December 31, 2008.) The landlord’s interest under the Lease is presently held by Lakeland Industrial, LLC, a Delaware limited liability company (“Landlord”), and the tenant’s interest under the Lease is presently held by BIOMEC Cardiovascular Inc., a Minnesota corporation (“Tenant”).
ENPATH MEDICAL, INC.Non-Employee Director and Medical Advisory Board Stock Option Agreement • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus • Minnesota
Pursuant to the Company’s 1999 Non-Employee Director and Medical Advisory Board Stock Option Plan (“Plan”), adopted in July 1999, for the purpose of encouraging ownership of shares of the Common Stock of the Company (“Common Shares”) by Non-Employee Directors and Medical Advisory Board Members (as defined in the Plan), the Company desires to afford Optionee an option to purchase Common Shares. This option does not qualify as an incentive stock option under Section 422A of the Internal Revenue Code of 1986, as amended.
AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus
This Amendment to Asset Purchase Agreement (the “Amendment”) is entered into as of this 14th day of March, 2005 among Enpath Medical Inc., a Minnesota corporation formerly known as Medamicus, Inc. (“Buyer”), Enpath Lead Technologies, Inc., a Minnesota corporation formerly known as Medacquisition, Inc. and a wholly-owned subsidiary of Buyer (“Acquisition Sub”), BIOMEC Inc., an Ohio corporation (“Parent”)and BIOMEC Technology Inc., a Minnesota corporation formerly known as BIOMEC Cardiovascular Inc. (“Subsidiary”).
Letter AgreementAsset Purchase Agreement Amendment • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus
This letter agreement is entered into as of this 15th day of March 2005 among Enpath Medical, Inc., a Minnesota corporation formerly known as Medamicus, Inc. (“Enpath”), BIOMEC Inc., an Ohio corporation (“BIOMEC”) and BIOMEC Technology Inc., a Minnesota corporation formerly known as BIOMEC Cardiovascular Inc. (“Subsidiary”) to document the agreement and understanding of the parties. Enpath, BIOMEC and Subsidiary agree as follows:
February 9, 2005 Enpath Medical, Inc. Attn: Mike Erdmann 15301 Highway 55 West Minneapolis, MN 55447Revolving Credit and Term Loan Agreement • March 24th, 2005 • Enpath Medical Inc • Surgical & medical instruments & apparatus
Pursuant to the provisions of Section 5.1(f) of the Revolving Credit And Term Loan Agreement (the “Loan Agreement”) dated October 17, 2003, the Borrower agreed it would maintain Tangible Net Worth of not less than $10,000,000 at December 31, 2004.
